UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $) In Thousands	Total	Common Stock	Additional Paid-In Capitol	Accumulated Other Comprehensive Income	Retained Earnings
Balance, value at Dec. 31, 2010	$ 37,792	$ 36	$ 107	$ (1,275)	$ 38,924
Balance, shares at Dec. 31, 2010		3,619
Common stock issued upon exercise of employee stock options	485	0	485
Common stock issued upon exercise of employee stock options, shares		21
Tax benefit attributable to appreciation of stock options	34		34
Stock option compensation expense	95		95
Common stock purchased and retired	0
Foreign currency translation adjustment	(1,628)			(1,628)
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	(3)			(3)
Common stock dividends	(3,433)				(3,433)
Net income	7,414				7,414
Balance, value at Dec. 31, 2011	40,757	36	721	(2,906)	42,904
Balance, shares at Dec. 31, 2011		3,640
Common stock issued upon exercise of employee stock options	1,941	1	1,940
Common stock issued upon exercise of employee stock options, shares		82
Common stock received and retired upon exercise of stock options	(138)	0	(138)
Common stock received and retired upon exercise of stock options, shares		(4)
Tax benefit attributable to appreciation of stock options	178		178
Stock option compensation expense	70		70
Common stock purchased and retired	(504)	0	(503)
Common stock purchased and retired, shares		(15)
Foreign currency translation adjustment	1,862			1,862
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	193			193
Common stock dividends	(3,555)				(3,555)
Net income	10,169				10,169
Balance, value at Dec. 31, 2012	50,972	37	2,268	(851)	49,519
Balance, shares at Dec. 31, 2012		3,703
Common stock issued upon exercise of employee stock options	1,403	1	1,402
Common stock issued upon exercise of employee stock options, shares		55
Common stock received and retired upon exercise of stock options	(701)	0	(701)
Common stock received and retired upon exercise of stock options, shares		(15)
Tax benefit attributable to appreciation of stock options	281		281
Stock option compensation expense	28		28
Common stock purchased and retired	0
Foreign currency translation adjustment	859			859
Unrealized holding gain (loss) from investments, available-for-sale, net of taxes	8			8
Common stock dividends	(3,675)				(3,675)
Net income	11,406				11,406
Balance, value at Dec. 31, 2013	$ 60,581	$ 37	$ 3,278	$ 16	$ 57,250
Balance, shares at Dec. 31, 2013		3,743